IL6 and renal fibrosis: During advanced disease, inhibitors of the IL-6 pathway, especially those targeting IL-6 trans-signaling, significantly inhibit the recruitment of M2 macrophages, CD4+ T cells in mouse kidneys (73, 74), thereby alleviating renal fibrosis.